Pick a time period -
No more available filters You need to apply a filter before selecting newsroom

Use our filters to get your customized news. Save and subscribe to as many filters as you want, get the news that YOU are interested in right in your mailbox, RSS feed or in your personalized dashboard. Share your stories, news, multimedia and pressreleases and get a wider audience with news.cision.com.

VR, eye tracking and biometrics come together as Tobii Pro extends software capabilities

Tobii Pro , the global leader in eye tracking research solutions, continues to expand its VR offering by announcing Tobii Pro Lab VR 360 . This new edition of Tobii Pro Lab, the company’s flagship analysis software, enables cognitive researchers, psychologists and marketing researchers to utilize 360-degree videos and images when conducting eye tracking studies in VR. The analysis software Tobii Pro Lab supports the entire workflow for designing, recording and analyzing eye tracking data collected from any of Tobii Pro’s screen-based and

Hedin Bil has entered an agreement to acquire another two Mercedes-Benz dealerships in Belgium

Once the deal has been finalized, Hedin Bil will be present at 14 locations in Belgium. The transaction is conditional upon approval of the Belgian Competition Authorities.Gothenburg, August 23, 2018 I.A. Hedin Bil has through its subsidiary, Hedin Belgien Bil AB, entered an agreement to acquire J-Automotive BVBA. The deal includes two full-service dealerships for Mercedes-Benz. Both dealerships operate under the brand Jacobs and are situated between Ghent and Antwerp, one in Lokeren and one in Sint-Niklaas. In 2017, the turnover was in the region of 100 million Euros and the business

Bittium launches new waterproof Bittium Faros™ ECG device and Bittium FastFix™ patch electrode at ESC Congress 2018

Press release Free for publication on August 23, 2018 at 2pm (CEST +1) Bittium launches new waterproof Bittium Faros™ ECG device and Bittium FastFix™ patch electrode at ESC Congress 2018 Oulu, Finland, August 23, 2018 – Bittium exhibits its innovative products and solutions for cardiology at ESC Congress 2018 on August 25-29 in Munich, Germany. ESC Congress is the world's largest conference in cardiovascular medicine organized by the European Society of Cardiology. At the event Bittium launches the new waterproof Bittium Faros™ ECG device and Bittium FastFix™ patch electrode for

Revenio Group Corporation: Managers' transactions

Revenio Group Corporation, Managers' transactions, August 23, 2018 at 14:00 Revenio Group Corporation: Managers' transactions Revenio Group Oyj - Managers' Transactions____________________________________________Person subject to the notification requirementName: Isomäki AriPosition: Other senior manager(X) Legal personIssuer: Revenio Group OyjLEI: 743700I27E0FWSXLKK04Notification type: INITIAL NOTIFICATIONReference number: 743700I27E0FWSXLKK04_20180823134639_2____________________________________________Transaction date: 2018-08-21Venue: FIRST NORTH FINLAND (

SimCorp A/S – Announcement of Managers’ Transactions

Announcement and public disclosure of transactions in SimCorp A/S shares by personsdischarging managerial responsibilities and persons closely associated with them 1. Details of the person with managerial responsibilities/person closely associateda) Name Morten Hübbe2. Reason for the notificationa) Position/status Board memberb) Initial Initial notification notification/Amendment3. Details of the issuer, emission allowance market participant, auction platform, auctioneer or

Nokian Tyres plc: Managers' transactions

Nokian Tyres plc Managers’ transactions August 23, 2018, 1:45 p.m. Person subject to the notification requirement  Name: Pantioukhov, Andrei (Natural Person)Position: Other senior manager IssuerName: Nokian Tyres plcLEI: 743700YQIO8Y4L4WKR40 Notification Initial Notificationtype: Reference 743700YQIO8Y4L4WKR40_20180822141314_3number:Transactiondetails Transaction 2018-08-21date: Venue:  NASDAQ HELSINKI LTD (XHEL) Nature of Disposal transaction: Instrument:  Financial instrument

Ayima Half Yearly Report 1, January to June 2018

Revenue increased by 48% in H1 2018, Margins Improve ·  Total Revenue amounted to 83.7 MSEK (56.6) an increase of 48% from the same period in 2017. ·  Total Revenue in H1 is already 65% of total for FY2017 and continuing to grow month on month ·  Gross Profit amounted to 43.9 MSEK, (34.1) an increase of 29% from the same period in 2017 ·  Profit after tax for the period amounted to -3.0 MSEK (-11.2), a 73% improvement. ·  Total Comprehensive Income amounted to -0.4 MSEK (-11.3), a 96% improvement ·  Balance Sheet assets amounted to 83.1 MSEK (71.7) ·  Net

Actic recruits Anders Carlbark as new CEO

Actic Group has recruited Anders Carlbark as new CEO. Anders joins Actic from H&M where he has been working the past decade, of which the two last years as Global Head of Merchandising. Anders will take up his new position in December 2018. Christer Zaar, the current CEO, will leave the company during the autumn.”We are very pleased to be able to recruit Anders Carlbark, after a wide process, as new CEO. His experience from creating relevant customer offers in combination with an international experience will be important in order to strengthen Actic’s customer relations as well as continue

Interim report January – June 2018

Robust growth and profitability with stable cash flowApril – June 2018 · Net sales increased by 50.2 percent to SEK 1,174 (781) million. Organic growth was 14.4 (–9.0) percent. · Adjusted EBITA increased to SEK 107 (69) million which corresponds to an adjusted EBITA margin of 9.1 (8.9) percent. · Operating cash flow for the quarter was SEK 125 (30) million. · Four acquisitions were made during the quarter, which, on an annual basis contribute an estimated total sales of SEK 238 million. · Earnings per share for the quarter amounted to SEK 1.52 (0.90). January – June 2018

Acarix presenting the CADScor®System at ESC in Munich: a revolutionary technology for early and rapid rule out of Coronary Artery Disease

Visit us at booth D500 Exhibition hall A2 Acarix AB’s (publ) (“Acarix”) ultra-sensitive acoustic CADScor®System for Coronary Artery Disease risk assessment will be on display at ESC in Munich, Germany, August 25-28. The CADScor®System has been validated clinically to rule out Coronary Artery Disease with 96 to 97% negative predictive value. The device is gaining interest and increased use across Germany and Denmark, key Swedish hospitals are testing the system and expansion in other European countries is under way. At ESC 2018, both in the exhibition booth and at a special session Tuesday

Biovica receives patent approval in Japan

Biovica International AB (publ) have received a new patent in Japan. The patent refers to Biovica's method of measuring thymidine kinase activity on a real-time PCR platform. The new patent is valid until 13th of May 2031. With this patent, Biovica has received patent protection for the PCR-based product on all 16 markets the company has applied for patent protection.”It is important for Biovica to protect our unique technology. Hence, it is positive news that we get improved patent protection on one of the more important markets. Patent protection is important in order to be able to bring

Talkpool issues up to SEK 24 million of senior secured notes

NOT FOR DISTRIBUTION, DIRECTLY OR INDIRECTLY, WITHIN OR TO THE UNITED STATES, AUSTRALIA, HONG KONG, JAPAN, CANADA, SWITZERLAND, SOUTH AFRICA OR NEW ZEALAND OR IN ANY OTHER JURISDICTION WHERE THE DISTRIBUTION OF THIS PRESS RELEASE WOULD BE UNLAWFUL. Talkpool AG (”Talkpool” or ”the Company”) issues two-plus-one year senior secured notes amounting to maximum SEK 24 million. The bond is not dilutive to existing shareholders.The senior secured notes, which was directed to the Swedish retail market, will bear a fixed coupon of 10 percent and mature in August 2020. At the time of maturity, the

FrontOffice signs investment credit facility for fintech investment of SEK 20 million

FrontOffice Nordic AB (publ) (”FrontOffice”) has signed an investment credit facility of SEK 20 million, reserved to develop both existing holdings and continued investments within fintech. The credit has unilateral conversion rights for FrontOffice.The investment credit is provided by FTCS Intressenter AB and provides FrontOffice with an unsecured credit of up to 20 MSEK over a three-year period to an annual interest rate of 8 % on long-term credit. The investment credit also provides FrontOffice with a one-sided right to convert, on one or more occasions, the outstanding amount of loan

The Swedish FSA approves the merger between Nordea Bank AB (publ) and Nordea Bank Abp

The Swedish Financial Supervisory Authority (SFSA) has authorised Nordea to execute the merger plan regarding the merger of Nordea Bank AB (publ) into Nordea Bank Abp. This is part of the preparation for executing the merger and re-domiciliation to Finland, a member state of the European banking union. Nordea welcomes the SFSA’s authorisation to execute the merger plan. It forms a significant step for Nordea’s move to the European Banking Union following the banking licence granted by the European Central Bank on 26 June 2018. The re-domiciliation is planned to take effect on 1

Fortum Charge & Drive opens the first high-power charging station for electric vehicles in Sweden

Sweden’s first high-power charging (HPC) station was opened today by Fortum Charge & Drive in partnership with McDonald’s. The station is located at McDonald’s in Kristinehamn, some 270 kilometers west of Stockholm and midway between Oslo and Stockholm.At Kristinehamn’s HPC station next generation EVs can charge about 250 km range in only 10 minutes time. This is 7 times faster than on the quick chargers that are on the market today. The new HPC charging station in Kristinehamn is part of the first High-Power Charging (HPC) corridor that Fortum Charge & Drive is building between Oslo,

Dignitana CEO William Cronin to Speak at Aktiespararna Event in Stockholm

Dignitana AB  announced today that Chief Executive Officer William Cronin will speak at Aktiespararna’s event Aktiedagen Stockholm  on 11 September 2018. Mr. Cronin’s 20-minute presentation will be webcast live starting at 11:20 am CEST and published the following day. Event attendees will have the opportunity to ask Mr. Cronin questions following his presentation. The event is hosted by Aktiespararna, an independent organization working in the interest of private individuals who invest in stocks,

Kleresca® releases unique biophotonic rosacea treatment

Ballerup, Denmark, August 2018. Kleresca®, a medical technology company focused on the development and commercialisation of a unique biophotonic technology in dermatology, today announced the release of a new treatment for rosacea.A new biophotonic treatment for rosacea is now available to patients through aesthetic clinics across 10 markets including Denmark, UK, France, Spain, Italy, Germany, Belgium, Norway, Australia and Switzerland.   The treatment is based on Kleresca®’s unique and patented biophotonic technology which uses fluorescent light energy to stimulate the skin’s own

NetEnt launches Berryburst times two as it debuts MAX product line

NetEnt has launched Berryburst and Berryburst MAX – the first double release from its groundbreaking, mixed volatility product line.Berryburst is a frenzy of floating and fluctuating fruity fragments in a 5-reel, 3-row video slot. It features the repeatedly successful Cluster Pays™ mechanic allowing players to see big wins together with the proven top performing expanding, stacked wild re-spins mechanic, but now across all 5 reels. Berryburst MAX broadens the new game’s appeal by offering a much higher win potential using the same NetEnt game mechanics as the regular version.

Invitation to presentation of Immunovia´s interim report January-June 2018 and comments to the previously published autoimmunity study results

Lund (Sweden) - Immunovia will publish the company’s interim report for the period January-June 2018 on Friday, August 24, at 08:30 a.m. CET.Immunovia invites to a teleconference (in English) for investors, analysts and media on August 24, at 4:00 – 5:00 p.m. CET. Mats Grahn, CEO will present Immunovia and comment on the interim report, as well as comment on the press release of August 22 regarding autoimmunity study results, followed by a Q&A-session. Please call in a few minutes in advance. To attend, please dial-in at one of the numbers below from: Telephone details:SE:

There are no items matching the current filter
There are no more items matching the current filter
Back to top